Philips Brings CT Planning Into Azurion With UniGuide 3D

Executive Summary

• Philips announced UniGuide 3D Live Guidance on Oct 29, 2026, describing a CE-marked solution that brings CT-derived planning information into the live Azurion workflow. Source
• Philips states the solution is CE marked and available for sale in CE-marked markets from October 23, 2026. Source
• Philips states UniGuide 3D Live Guidance is currently not available for sale in the United States. Source

Key Takeaways

• The first release connects preprocedural CT insights to the live Azurion workflow for PCI, structural heart and complex vascular procedures, according to Philips.
• For CT-guided PCI, Philips says information derived from a coronary CT angiography scan can be combined with live image guidance through 3D overlay visualization or synchronized side-by-side display.
• Philips describes an open planning ecosystem allowing planning insights from its Advanced Visualization Workspace and compatible third-party solutions, subject to meeting the Philips DICOM conformance statement.
• Philips cites a March 2026 usability study in which 93% of 15 participating clinicians believed bringing planning information into the procedural workflow could help improve cath lab efficiency and performance; this is perception data, not outcome evidence.

Philips Announcement Timing Versus Market Availability

The publisher page is dated Oct 29, 2026, which is the announcement date. The commercial availability statement is separate: Philips says the solution is CE marked and available for sale in CE-marked markets from October 23, 2026. Readers should not conflate the two dates. The announcement signals a communication milestone, while the October 23 date is the earliest commercial availability cited for CE-marked markets. Philips frames the launch as occurring in Europe and other CE-marked markets. No United States availability date is given; the page states the product is currently not available for sale in the United States. Our editorial recommendation is that procurement teams verify current local availability and labeling directly with Philips rather than inferring status from the announcement date.

Philips Workflow Integration and Display Claims

Philips positions UniGuide as fully integrated into the Azurion workflow. According to the source, physicians can access CT and planning information on the large FlexVision display and interact with 3D guidance through the tableside Touch Screen Module. The page states the design aims to minimize the need to move between systems and workstations. A quoted clinician, Prof. Javier Escaned of Hospital Clínico San Carlos and Complutense University, Madrid, describes reviewing CT aspects inside the cathlab using the table-side touchscreen and synchronizing the movement of the 3D CT rendering with the C-arm. These are attributed statements describing intended use and user experience, not measured clinical results. Philips also states the first release supports more informed, patient-specific treatment decisions in PCI, structural heart and complex vascular procedures. No independent clinical validation is presented on the page.

Philips Usability Signals

The table rows reflect only entities named in the publisher page. The usability study is described as a Philips claims substantiation study performed in March 2026, with responses from 15 clinicians in the United States who completed a questionnaire after a usability study and additional hands-on time. Philips reports that 93% believed bringing planning information into the procedural workflow could help improve cath lab efficiency and performance, and 80% indicated that automation and intuitive user experience could help physicians maintain focus. The wording is about belief and potential, not demonstrated improvement in patient outcomes. Readers should treat these figures as vendor-reported perception data from a small sample.

Philips Open Ecosystem and Compatibility Conditions

Philips states that UniGuide supports an open planning ecosystem, allowing providers to use planning insights from Philips Advanced Visualization Workspace and compatible third-party solutions within the live Azurion workflow. The page attaches a condition: the preprocedural planning solution should meet the DICOM conformance statement issued by Philips. Philips argues this flexibility helps protect existing investments and gives providers greater choice in planning and guidance. The page does not name specific third-party vendors or list validated compatibility beyond the DICOM condition. Our editorial recommendation is that buyers obtain written compatibility confirmation for their existing planning software before assuming integration, since the source describes a conformance requirement rather than a blanket compatibility guarantee.

Philips Implementation Risks

Several source-bounded considerations arise from the page. First, availability is limited to CE-marked markets, with no United States sale stated, so any deployment planning outside those markets is unsupported by the source. Second, integration depends on third-party planning solutions meeting Philips DICOM conformance statements, which places a diligence burden on providers. Third, the evidentiary base presented is a vendor usability study with 15 clinicians and questionnaire responses about perceived potential, not clinical outcome data; the page offers no efficacy figures, trial results or regulatory clearances beyond the CE mark. Fourth, workflow benefits are described aspirationally, including minimizing movement between systems. Our editorial recommendations: request local labeling and instructions for use, confirm compatibility in writing, plan staff training around the FlexVision display and tableside Touch Screen Module described by Philips, and define internal success metrics before deployment. These are our editorial recommendations, not measured results, and they should not be read as evidence of clinical or financial benefit.

Philips Stated Direction Beyond This Release

Philips describes UniGuide as part of a broader strategy to build on Azurion and create a more connected environment for image-guided therapy, bringing planning, diagnostic and procedural information into a single workflow. The page states that over time Philips intends to expand this foundation across multiple imaging modalities, clinical applications and procedure types. These are stated intentions, not confirmed timelines or capabilities. The page also characterizes Azurion as widely adopted and known for workflow efficiency and user experience, a vendor characterization rather than an independently verified finding. Chief Medical Officer Darshan Doshi is quoted saying UniGuide connects CT planning with live guidance to help physicians make more informed, patient-specific decisions. No financial terms, pricing or sales targets appear in the source.

What This Means for Practitioners

For interventional teams in CE-marked markets, the source indicates a CE-marked option that places preprocedural CT information inside the Azurion workflow, including 3D overlay visualization or synchronized side-by-side display for CT-guided PCI, and access on the FlexVision display with tableside interaction. Practitioners evaluating it should note that Philips attributes efficiency and focus benefits to clinician perceptions in a 15-participant usability study, not to measured patient outcomes, and that third-party planning integration depends on DICOM conformance. Teams outside CE-marked markets, including the United States, have no stated availability. Our editorial recommendation is to treat the announcement as a workflow-integration proposition requiring local verification, compatibility checks and internal evaluation before any clinical adoption decision.

Editorial independence disclosure: Our recommendations reflect editorial judgment based on the supplied publisher page. They are not independent product testing, clinical validation or third-party verification. Source note: all factual claims are attributed to Philips at the publisher page. Related reading, not used as source evidence: Related Health Tech coverage, Related Health Tech coverage, Related Health Tech coverage.